Article (Scientific journals)
The Belgian MIRA (MabThera In Rheumatoid Arthritis) registry: clues of the optimization of rituximab treatment strategies.
Vander Cruyssen, B.; Durez, P.; Westhovens, R. et al.
2010In Arthritis Research and Therapy, 12 (5), p. 169
Peer Reviewed verified by ORBi
 

Files


Full Text
Vander Cruyssen_Arthritis Research Therapy_2010_12_R169.pdf
Publisher postprint (533.05 kB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
The Belgian MIRA registry
Disciplines :
Rheumatology
Author, co-author :
Vander Cruyssen, B.
Durez, P.
Westhovens, R.
KAISER, Marie-Joëlle ;  Centre Hospitalier Universitaire de Liège - CHU > Rhumatologie
Hoffman, I.
De Keyser, F.
MIRA Study Group
Other collaborator :
Malaise, Michel ;  Université de Liège - ULiège > Département des sciences cliniques > Rhumatologie
Language :
English
Title :
The Belgian MIRA (MabThera In Rheumatoid Arthritis) registry: clues of the optimization of rituximab treatment strategies.
Publication date :
10 September 2010
Journal title :
Arthritis Research and Therapy
ISSN :
1478-6354
eISSN :
1478-6362
Publisher :
BioMed Central, London, United Kingdom
Special issue title :
Arthritis Res Ther.
Volume :
12
Issue :
5
Pages :
169
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 01 February 2012

Statistics


Number of views
172 (4 by ULiège)
Number of downloads
1 (1 by ULiège)

Scopus citations®
 
20
Scopus citations®
without self-citations
18
OpenCitations
 
13

Bibliography


Similar publications



Contact ORBi